Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Rezafungin
.
Show all posts
Showing posts with label
Rezafungin
.
Show all posts
Monday, October 10, 2022
Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
›
Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patien...
›
Home
View web version